Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.76 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.71 |
| ▸ | TSHR | P16473 | 8/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 5/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.51 |
| ▸ | KDR | P35968 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31490936 | 0.98 | ALDH1A1 (0.79) | ALDH1A1TDP1TSHRL3MBTL1CYP3A4 | |
| SCHEMBL39575 | 0.98 | ALDH1A1 (0.79) | ALDH1A1TDP1TSHRL3MBTL1CYP3A4 | |
| SCHEMBL27856813 | 0.96 | ALDH1A1 (0.76) | ALDH1A1TDP1TSHRL3MBTL1CYP3A4 | |
| Alcohol SCHEMBL28094806 | 0.95 | ALDH1A1 (0.73) | ALDH1A1TDP1TSHRL3MBTL1CYP3A4 | |
| Bicarbonate SCHEMBL21753664 | 0.95 | ALDH1A1 (0.73) | ALDH1A1TDP1TSHRL3MBTL1CYP3A4 | |
| Bicarbonate SCHEMBL30206837 | 0.95 | ALDH1A1 (0.73) | ALDH1A1TDP1TSHRL3MBTL1CYP3A4 | |
| Benzene SCHEMBL28044051 | 0.95 | ALDH1A1 (0.73) | ALDH1A1TDP1TSHRL3MBTL1CYP3A4 | |
| Ethyl Salicylate SCHEMBL27816869 | 0.93 | ALDH1A1 (0.71) | ALDH1A1TDP1TSHRL3MBTL1CYP3A4 | |
| Methyl Salicylate SCHEMBL9229811 | 0.92 | TSHR (0.71) | ALDH1A1TDP1TSHRL3MBTL1CYP3A4 | |
| Salicylic Acid SCHEMBL27810342 | 0.92 | ALDH1A1 (0.69) | ALDH1A1TDP1TSHRL3MBTL1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 677 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250041216-A1 | Methotrexate Composition | ROSEMONT PHARMACEUTICALS LTD (GB) | 2025-02-06 | — | — | US | claimed |
| CN-116098978-B | Chinese medicinal cream for treating psoriasis and preparation method thereof | 北京斯利安药业有限公司 | 2024-07-19 | — | — | CN | claimed |
| US-11969503-B2 | Methotrexate composition | ROSEMONT PHARMACEUTICALS LTD (GB) | 2024-04-30 | — | — | US | claimed |
| CN-114762655-B | Oral cavity efficient nursing composition and preparation method and application thereof | 广州赛葆力医疗器械有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-117065037-A | Pharmaceutical compositions comprising S1P modulators | 诺华股份有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-116942606-A | Preparation method of lamotrigine suspension and dry suspension | 上海奥科达医药科技股份有限公司 | 2023-10-27 | — | — | CN | claimed |
| US-20230233464-A1 | Methotrexate Composition | ROSEMONT PHARMACEUTICALS LTD (GB) | 2023-07-27 | — | — | US | claimed |
| CN-116399980-A | Method for detecting preservative in protein iron succinate oral solution | 江苏慧聚药业股份有限公司 | 2023-07-07 | — | — | CN | claimed |
| CN-116098978-A | Chinese medicinal cream for treating psoriasis and preparation method thereof | 北京斯利安药业有限公司 | 2023-05-12 | — | — | CN | claimed |
| CN-114948868-B | Crystal form of lamotrigine hydrate, preparation method thereof and composition containing crystal form | 上海奥科达医药科技股份有限公司 | 2023-04-14 | — | — | CN | claimed |
| CN-1561989-A | Soybean aglycone soft capsule and its preparing method | SHAO AIXIA (CN) | 2005-01-12 | — | — | CN | claimed |
| CN-1528290-A | Andrographolide soft capsule and preparing method thereof | 西安千禾药业有限责任公司 | 2004-09-15 | — | — | CN | claimed |
| CN-1460019-A | Improved injectable dispersions of propofol | SKEY MEDICINE CANADA INC (CA) | 2003-12-03 | — | — | CN | claimed |
| CN-1430965-A | Soft capsule of puerarin and preparing method thereof | CHENG SHOUHUI (CN) | 2003-07-23 | — | — | CN | claimed |
| US-20030130267-A1 | Pharmaceutical composition | SPECIAL PRODUCTS LIMITED | 2003-07-10 | — | — | US | claimed |
| EP-1323422-A1 | Pharmaceutical composition comprising midazolam for buccal administration | Special Products Limited (GB) | 2003-07-02 | — | — | EP | claimed |
| CN-1069520-C | Breviscapine soft capsule and its production method | KUNMING PHARMACEUTICAL CO LTD (CN) | 2001-08-15 | — | — | CN | claimed |
| CN-1069519-C | Bulleyaconitine A soft capsule and its production method | KUNMING PHARMACEUTICAL CO LTD (CN) | 2001-08-15 | — | — | CN | claimed |
| CN-1228958-A | Bulleyaconitine A soft capsule and its production method | KUNMING PHARMACEUTICAL CO LTD (CN) | 1999-09-22 | — | — | CN | claimed |
| CN-1228959-A | Breviscapine soft capsule and its production method | KUNMING PHARMACEUTICAL CO LTD (CN) | 1999-09-22 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030130267-A1 | Pharmaceutical composition | CYP3A5, CYP3A7, CYP3A43 | ALDH1A1 1169/4885TDP1 3323/4885TSHR 3224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.